127 related articles for article (PubMed ID: 6014890)
1. [Increased tolerance toward coronary occlusion through a pharmacologically increased vascular network].
Schmidt HD; Schmier J
Arzneimittelforschung; 1966 Aug; 16(8):1058-64. PubMed ID: 6014890
[No Abstract] [Full Text] [Related]
2. [Questioning the coronary flow deviation induced by dipyridamole].
Gomes OM
Arq Bras Cardiol; 1985 May; 44(5):319-22. PubMed ID: 2936322
[No Abstract] [Full Text] [Related]
3. [Vasodilator agents and collateral coronary circulation. I. Dipyridamole. Study of the isolated heart].
Gomes OM; Duarte JV; Gontijo R; Higa SS; Monteiro EL
Arq Bras Cardiol; 1985 Jul; 45(1):27-9. PubMed ID: 3833123
[No Abstract] [Full Text] [Related]
4. [The effect of selective serotonin administration into different portions of the coronary vascular bed on the retrograde (collateral) coronary blood flow in myocardial ischemia in dogs].
Azarov VI; Hrabovs'kyĭ LO; Moĭbenko OO
Fiziol Zh (1994); 1999; 45(1-2):26-34. PubMed ID: 10202633
[TBL] [Abstract][Full Text] [Related]
5. [Effect of diprazin and dimedrol on the collateral coronary blood circulation].
Gubarev EA; Pichugin VV
Farmakol Toksikol; 1967; 30(6):681-4. PubMed ID: 5598435
[No Abstract] [Full Text] [Related]
6. Effect of norepinephrine upon coronary collateral blood flow after experimental coronary artery occlusion.
Edlich RF; Quattlebaum FW; Lillehei CW
J Thorac Cardiovasc Surg; 1969 Jul; 58(1):33-8. PubMed ID: 5790434
[No Abstract] [Full Text] [Related]
7. Increase in myocardial collateral capacity following drug-induced coronary vasodilatation. A preliminary report.
Rees JR; Redding VJ
Am Heart J; 1969 Aug; 78(2):224-8. PubMed ID: 4894487
[No Abstract] [Full Text] [Related]
8. [Pharmacologically-induced development of coronary collaterals in relation to dosage].
Meesmann W; Bachmann GW
Arzneimittelforschung; 1966 Apr; 16(4):501-9. PubMed ID: 6014261
[No Abstract] [Full Text] [Related]
9. Effect of epinephrine on coronary collateral blood flow following coronary artery occlusion.
Edlich RF; Quattlebaum FW; Lillehei CW
Angiology; 1970 May; 21(5):299-304. PubMed ID: 4910120
[No Abstract] [Full Text] [Related]
10. Global and regional haemodynamic effects of urapidil in conscious dogs with chronic coronary artery occlusion.
Wouters PF; Marcus MA; Van Aken HK; van de Velde M; Miserez M; Deruyter HA; Mignolet K; Flameng W
Eur J Anaesthesiol; 1994 Sep; 11(5):381-90. PubMed ID: 7988582
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of the effect of strophanthin on collateral coronary circulation].
Borovskikh LG
Biull Eksp Biol Med; 1966 Apr; 61(4):70-3. PubMed ID: 6005347
[No Abstract] [Full Text] [Related]
12. [The comparative studies on the influence of persantin on the coronary circulation in dogs and rabbits].
Filczewski M; Oledzka K; Nowicka J
Acta Physiol Pol; 1969; 20(1):155-63. PubMed ID: 5793303
[No Abstract] [Full Text] [Related]
13. Pharmacological, rheological and surgical attempts to improve myocardial blood flow during coronary occlusion in dogs.
Seeman T
Acta Chir Scand Suppl; 1969; 400():3-27. PubMed ID: 4986592
[No Abstract] [Full Text] [Related]
14. Augmentation of coronary collaterals and protection against the consequences of coronary ligation following the administration of dipyridamole.
Schmier J; Kaden F; Schmidt HD
Brux Med; 1970 Sep; 50(9):617-22. PubMed ID: 5510362
[No Abstract] [Full Text] [Related]
15. [Effect of dilating agents on collateral coronary circulation and oxygen tension in the myocardium].
Sapozhikov AV
Farmakol Toksikol; 1968; 31(6):687-90. PubMed ID: 5713578
[No Abstract] [Full Text] [Related]
16. [Experimental coronary flow reversal in the desending region of the canine heart].
Török B; Babotai I; Largiadèr F; Senning A
Z Gesamte Exp Med Einschl Exp Chir; 1968; 148(2):81-9. PubMed ID: 5725643
[No Abstract] [Full Text] [Related]
17. Experimental myocardial infarction in the dog. Comparison of myocardial blood flow within, near, and distant from the infarct.
Rees JR; Redding VJ
Circ Res; 1969 Aug; 25(2):161-70. PubMed ID: 4896650
[No Abstract] [Full Text] [Related]
18. [Some characteristics of the effect of cardiac glycosides on collateral coronary circulation during administration of antihistaminic preparations].
Gubarev EA; Pichugin VV
Farmakol Toksikol; 1968; 31(5):590-3. PubMed ID: 5707734
[No Abstract] [Full Text] [Related]
19. [The formation of collaterals in the coronary vascular system of the dog. Experimental proof of the collateral formation in the dog heart following prenylamine-lactate treatment].
Starey F
Arzneimittelforschung; 1972 Aug; 22(8):1317-20. PubMed ID: 4678393
[No Abstract] [Full Text] [Related]
20. [On the protective action of coronary vessel collaterals].
Schmitt G; Hauss W
Arzneimittelforschung; 1967 Aug; 17(8):959-64. PubMed ID: 5632069
[No Abstract] [Full Text] [Related]
[Next] [New Search]
